All News
Prevalence of Cardiovascular Disease in Rheumatoid Arthritis
A prospective study of the BioSTAR registry estimates the prevalence of cardiovascular disease in rheumatoid arthritis (RA) to be 4.6%.
Read Article
You can still attend RheumNow Live!
Below is a preview of one of our "STEP" talks - by Mike Putman, MD, who brings his vast knowledge to the forefront, shedding light on Myths & Mistakes on ANCA-Associated Vasculitis.
https://t.co/LzcVytLDij
Register: https://t.co/NWXKNhQzc5 https://t.co/ogAfTtH5Nk
Dr. John Cush RheumNow ( View Tweet)
You can still attend RheumNow Live!
Below is a preview of one of our "STEP" talks - by Mike Putman, MD, who brings his vast knowledge to the forefront, shedding light on Myths & Mistakes on ANCA-Associated Vasculitis.
https://t.co/LzcVytLDij
Register: https://t.co/NWXKNhQzc5 https://t.co/ogAfTtH5Nk
Links:
Dr. John Cush RheumNow ( View Tweet)
New download available!
Seasonal Flu Vaccination in RA Patients
https://t.co/tNwgUVoG7Z https://t.co/P1UqPU57WU
Dr. John Cush RheumNow ( View Tweet)
Japanese retrospective study compared RA pts on JAK inhib vs bDMARDs (n=62 ea) having orthopedic surgery; JAKi- pts had more postoperative flares (29% v 12%, P=.01), esp if JAKi held >11d (p.04). No diff in other postop complications https://t.co/NVY1Oajdve https://t.co/fwc9KWYZ9l
Links:
Dr. John Cush RheumNow ( View Tweet)
Metanlysis of 49 studies, 10 RCTs examined the relationship between RA and non-surgical Rx of periodontitis (NSRT) and in general short term studies show that NSPT benefits RA patients; and DMARD therapy benefits periodontitis https://t.co/Bw66VrIMp2 https://t.co/v9SG3sdeni
Dr. John Cush RheumNow ( View Tweet)
Methotrexate Nodulosis (1.19.2024)
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. How good (or not) are rheumatologists and what to do about MTX nodulosis?
Read Article
QD Clinic - RA, SSZ, & MI
RA with a myocardial inflarction - which DMARD?
https://t.co/FqnouGylMN https://t.co/KzmLctKZBI
Dr. John Cush RheumNow ( View Tweet)
Fertility and Rheumatoid Onset
British women whose capability of bearing children either started late or ended early -- were at increased risk for developing RA, compared with women with earlier menarche or later menopause, researchers found.
https://t.co/SwxTvntqY2 https://t.co/bmwrLWwtke
Dr. John Cush RheumNow ( View Tweet)
QD Clinic - To Aspirate or Not
RA patient in need to an injection; do you aspirate first?
https://t.co/lOA5glSmfs https://t.co/FUvBFa8H7Q
Dr. John Cush RheumNow ( View Tweet)
Mayo study shows multimorbidity in RA increases serious infx (SI) risk; 911 RA pts (56 yrs, 2/3 seropositive) 17% had SI (3.9/100PY). Hi risk morbidities(bipolar Dz, CKD, COPD,, chr skin ulcers) were assoc w/ 3 to 5-fold increased SI risk https://t.co/qorKp96KTm https://t.co/o5FaMKMskA
Dr. John Cush RheumNow ( View Tweet)
Fertility and Rheumatoid Onset
d
MedPage Today
British women whose capability of bearing children either started late or ended early -- naturally or otherwise -- were at increased risk for developing rheumatoid arthritis (RA), compared with women with earlier menarche or later menopause, researchers found.
Read Article
Retrospective study of 170 #RA on TNFi (Inflx 53%, ADA 28%, CZP 19%). RF, CCP, Drug levels, anti-Drug Abs done.@6 mos HI baseline RF linked to lower drug levels for IFX & ADA; but not CZP. IFX/ADA Hi-RF pts had more dropouts vs CZP (80%/75%/33%, p=0.002) https://t.co/AIgJNkzcWu https://t.co/pQmfmLoFwe
Dr. John Cush RheumNow ( View Tweet)
Real-world data of 5070 RA pts (1816 Rx w/ b/tsDMARDs) showed the use of tsDMARD considerably increased from 2012 to 2021. All b/tsDMARDs pts improved Dz activity & function/ 10 yr effiicacy best for IL6Ri in switch pts and ABA in bNAIVE pts https://t.co/h9j8Pk03if https://t.co/gC7Wloujm0
Dr. John Cush RheumNow ( View Tweet)
Metanlysis of 49 studies, 10 RCTs examined the relationship between RA and non-surgical Rx of periodontitis (NSRT) and in general short term studies show that NSPT benefits RA patients; and DMARD therapy benefits periodontitis https://t.co/HeBA6xtw2O https://t.co/J2QUYVk3gE
Dr. John Cush RheumNow ( View Tweet)
Experience the Future of Rheumatology at RheumNow Live 2024, just two weeks away!
Don't miss out – secure your spot today for an unforgettable journey into the latest advancements and insights.
https://t.co/bbnb97MOHO https://t.co/QXO34ZmP2i
Links:
Dr. John Cush RheumNow ( View Tweet)
QD Clinic - ANA Positivity in RA
Considering an ANA+ Seropositive RA Patient
https://t.co/q0g0JsSWGu https://t.co/nXcEZbbEXG
Dr. John Cush RheumNow ( View Tweet)
2023 Rheumatology Year in Review
Dr. Jack Cush reviews highlights, advances and hot topics in rheumatology from 2023 and the RheumNow website.
2023 was a year of growth and new horizons while returning to operational and practice standards (in care and education) established before the pandemic.
Read Article
Hormonal Status Increases RA Risk
Early menopause—before the age of 45—taking hormone replacement therapy (HRT), and having 4 or more children are among several hormonal and reproductive factors linked to a heightened risk of RA in women.
https://t.co/Rz6rzkOHV5 https://t.co/UYjgs0MBv5
Dr. John Cush RheumNow ( View Tweet)
Insurance claims data compared 33k RA to 1079 PM/DM pts and showed overall lower use of statin R in PM/DM (27% vs 181%, p<0.0001). But if DM/PM-HLD pts used statins they had lower mortality rate than non-users (HR = 0.515, p = 0.0273) https://t.co/El0mmNZ8ZR https://t.co/428YmGlV5k
Dr. John Cush RheumNow ( View Tweet)